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Abstract
Background: Mastitis in dairy cattle results from infection of mammary tissue by a range of micro-
organisms but principally coliform bacteria and Gram positive bacteria such as Staphylococcus
aureus. The former species are often acquired by environmental contamination while S. aureus is
particularly problematic due to its resistance to antibiotic treatments and ability to reside within
mammary tissue in a chronic, subclinical state. The transcriptional responses within bovine
mammary epithelial tissue subjected to intramammary challenge with S. aureus are poorly
characterised, particularly at the earliest stages of infection. Moreover, the effect of infection on
the presence of bioactive innate immune proteins in milk is also unclear. The nature of these
responses may determine the susceptibility of the tissue and its ability to resolve the infection.
Results: Transcriptional profiling was employed to measure changes in gene expression occurring
in bovine mammary tissues sampled from three dairy cows after brief and graded intramammary
challenges with S. aureus. These limited challenges had no significant effect on the expression
pattern of the gene encoding β-casein but caused coordinated up-regulation of a number of
cytokines and chemokines involved in pro-inflammatory responses. In addition, the enhanced
expression of two genes, S100 calcium-binding protein A12 (S100A12) and Pentraxin-3 (PTX3)
corresponded with significantly increased levels of their proteins in milk from infected udders. Both
genes were shown to be expressed by mammary epithelial cells grown in culture after stimulation
with lipopolysaccharide. There was also a strong correlation between somatic cell count, a widely
used measure of mastitis, and the level of S100A12 in milk from a herd of dairy cows. Recombinant
S100A12 inhibited growth of Escherichia coli in vitro and recombinant PTX3 bound to E. coli as well
as C1q, a subunit of the first component of the complement cascade.
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Conclusion: The transcriptional responses in infected bovine mammary tissue, even at low doses
of bacteria and short periods of infection, probably reflect the combined contributions of gene
expression changes resulting from the activation of mammary epithelial cells and infiltrating immune
cells. The secretion of a number of proinflammatory cytokines and chemokines from mammary
epithelial cells stimulated by the bacteria serves to trigger the recruitment and activation of
neutrophils in mammary tissue. The presence of S100A12 and PTX3 in milk from infected udder
quarters may increase the anti-bacterial properties of milk thereby helping to resolve the mammary
tissue infection as well as potentially contributing to the maturation of the newborn calf epithelium
and establishment of the newborn gut microbial population.
Background
Mastitis in dairy cattle continues to be an economically
important disease. Despite extensive management prac-
tices including antibiotic treatments, mastitis is estimated
to cause annual losses in excess of two billion dollars per
annum in the United States alone [1,2]. These losses arise
from reduction in milk yield, waste of milk unfit for con-
sumption, antibiotic use and premature culling. The dis-
ease can be caused by a wide range of Gram negative
coliform and Gram positive bacteria, as well as yeast,
fungi and mycoplasma. However, contagious mastitis,
which is transmitted from cow to cow during milking, is
principally caused by Staphylococcus aureus [3]. Unlike
many other major mastitis-causing pathogens, which are
generally associated with acute infections acquired from
environmental reservoirs of bacteria, S. aureus causes
chronic subclinical infections. Control is complicated by
a high prevalence of resistance to antibiotics [4]. The abil-
ity of this bacterium to live within some cells and encap-
sulated nodules in mammary tissue may contribute to its
resistance to antibiotic treatments [5-7].
The innate immune system in mammals is one of the first
lines of host defense to infection as it has the capacity to
immediately recognise and respond to the earliest signs of
infection. Both acute and chronic mastitis conditions are
associated with a dramatic increase in somatic cell count
(SCC) in milk, with neutrophils being the predominant
leukocyte found in both the infected mammary quarter
and milk [8,9]. Neutrophils are essential cellular compo-
nents of the innate immune system [10] and their accu-
mulation and activation at the site of infection requires
local induction of a panel of innate immune molecules,
including various chemokines and cytokines [11]. Early
innate immune responses also occur in mammary epithe-
lial cells and these responses underpin subsequent neu-
trophil infiltration into mammary tissue, the activation of
these innate immune cells and increases in milk SCC [12-
14].
Several studies have examined gene expression in circulat-
ing leukocytes close to parturition, a time when cows are
more susceptible to mastitis infection, as well as during
acute mastitis infections [10,15,16]. These studies and
others using mammary tissue demonstrated that expres-
sion of a number of genes involved in immune cell activa-
tion, chemotaxis and apoptosis was altered [11,17,18].
Moreover, these gene expression changes have often been
shown to translate into corresponding protein expression
alterations thereby demonstrating that transcriptional
mechanisms primarily control the innate immune
response [19-21]. The majority of these studies used infec-
tion models that resulted in very strong mammary tissue
responses, or measured the responses relatively late after
experimental inoculation or during acute naturally
acquired clinical mastitis when significant necrotic dam-
age may have been evident.
Recent studies have begun to elucidate the direct role of
mammary epithelial cells (MEC) in the stimulation of the
innate immune response [12,14,22]. These studies indi-
cate that MEC respond robustly and rapidly to challenge
by either low levels of bacteria or bacterial cell wall com-
ponents with marked changes in expression of pro-
inflammatory cytokines and chemokines [23]. This
response probably underpins the subsequent infiltration
of mammary tissues by immune cells, particularly neu-
trophils [8,9]. A broader and more comprehensive exam-
ination of gene expression changes produced in
mammary epithelial cells and infiltrating immune cells in
response to mammary tissue infection with S. aureus may
identify the network of gene expression changes that coor-
dinates the early innate immune responses of this tissue.
Of particular interest are the local mammary tissue
responses after initial infection with low numbers of bac-
teria before the onset of widespread tissue damage.
Microarray technology has become an important tool to
address complex biological questions by simultaneously
measuring the expression of thousands of genes within a
tissue. Identification of patterns of gene expression can
provide insight into the biological functions of their
encoded proteins and the networks of protein interactions
governing responses of cells to extracellular stimuli. One
aim of the current study was to identify the network of
genes that becomes activated in mammary tissue inBMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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response to a brief and graded intramammary challenge
with S. aureus. The identification of these poorly charac-
terised genes and in-depth characterisation of their corre-
sponding proteins may be important for the development
of novel strategies to enhance resistance of cows to masti-
tis and the development of novel antibacterial therapeutic
agents. The consequences of these responses in terms of
potential secretion of bioactive innate immune proteins
into milk may also have relevance to the suckling calf.
Thus, a second aim is to characterise the biological activi-
ties of innate immune proteins that may be present in
milk from infected udder quarters.
Results
S. aureus challenge of bovine mammary tissue
To ensure that the dairy cows used in the experiment were
free from bacterial infection, milk samples were taken
from each udder quarter 24 h and 48 h prior to intramam-
mary S. aureus infusions and tested for bacterial growth.
All quarters from two cows and three quarters from a third
cow showed no bacterial growth. Milk from one quarter of
one cow (1419) showed low level growth of S. aureus 24
h prior to the commencement of the experiment, presum-
ably from a mild field mastitis infection. Consequently,
this quarter was excluded from the experiment. One quar-
ter of each cow was treated with pyrogen-free PBS and this
quarter acted as the intra-animal control for subsequent
analyses. Each cow received different graded doses of S.
aureus (strain JG80) by intramammary infusion, ranging
from 5 × 102 to 1 × 106 bacteria (Table 1).
Milk samples were also taken from each quarter 16 h after
S. aureus experimental infusion and tested for bacterial
growth. The bacterial culture was identified and tested for
hemolysis, catalase and coagulase activities (Table 2). All
milk samples from the quarters experimentally infused
with S. aureus contained bacteria with positive catalase
and coagulase activities and at least partial hemolysis
activity on blood agar plates. The bacteria in all of these
samples were identified as S. aureus. The milk samples
from quarters infused with pyrogen-free PBS had no S.
aureus growth, which was consistent with the view that
each quarter within an udder is a semi-autonomous phys-
iological unit and can be considered an independent
experimental unit during this relatively brief experimental
bacterial challenge [24-26].
Quantitative RT-PCR (qRT-PCR) was used to measure the
expression patterns of selected genes in mammary tissue
samples taken from each animal 16 h after the S. aureus
infusion (Fig. 1). There were no significant changes in the
expression levels of α-S1-casein  (CSN1S1) or β-casein
(CSN2) as a function of bacterial dose compared with
each intra-animal control sample (P > 0.05) for all three
cows (Fig. 1(a)). Therefore, the relatively low doses of S.
aureus in combination with the relatively brief infection
period did not affect the expression of these milk protein
genes in any quarter. This indicates that the experimental
model was a good representation of the early stages of
infection before there was significant tissue damage lead-
ing to the suppression of normal physiological functions.
The expression patterns of the pro-inflammatory
cytokines tumor necrosis factor alpha (TNFα), interleukin
1 beta (IL-1β), interleukin 8 (IL-8), interleukin 6 (IL-6)
and CD14 antigen (CD14), a pivotal cell surface protein
mediating detection of bacterial cell wall components,
were measured as representatives of early response innate
immune genes that are typically up-regulated by bacterial
infections of mammary tissue [12,14,27]. For each of
these genes, and within each cow, there were strong and
significant responses to the highest bacterial doses com-
pared with each intra-animal control (P < 0.01) (Fig.
1(b)). Moreover, the responses were dose-dependent, or
at least partially so. However, the magnitudes of the fold-
changes in gene expression were variable across the three
cows for each gene. For example, at a dose of 1 × 105 bac-
teria, the fold changes for TNFα were 39.8 (cow 1419),
26.2 (cow 1490) and 7.8 (cow 1592) (all P < 0.01). Fur-
thermore, the responses of samples from cow 1419 for all
of the measured pro-inflammatory cytokines were more
pronounced than the responses in the two other cows. For
IL-8 the fold changes were much greater compared with
TNFα and also more pronounced in cow 1419. The fold
changes for IL-8 were 603 and 2835 at the bacterial doses
of 1 × 105 and 1 × 106, respectively for cow 1419, while
corresponding figures for cow 1592 were 122 and 75 fold
(all P < 0.01).
Microarray analyses of mammary tissue challenged with 
different doses of S. aureus
We used the Bovine Innate Immune Microarray [28] to
identify a more complete repertoire of differentially
expressed transcripts in bovine udder tissues from the
three dairy cows challenged by intramammary infusion
with S. aureus. It was clear from the cow to cow variations
in the initial gene expression data that each cow required
independent assessment (Fig. 1(b)). Consequently, an
'All-Pairs' experimental design was used for each cow i.e.
each sample taken from one cow was tested against all
other samples from the same cow with each comparison
also involving dye swaps (Fig. 2). In this manner, every
Table 1: Dose of S. aureus (bacteria/5 ml) given by 
intramammary infusion into each udder quarter
Cow Left Fore Right Fore Left Hind Right Hind
1490 PBS 5 × 102 1 × 104 1 × 105
1592 1 × 104 PBS 1 × 105 1 × 106
1419 PBS nil1 1 × 105 1 × 106
1 This quarter was not usedBMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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sample was measured a total of six times, which allowed
identification of differentially expressed genes with
respect to the intra-animal control with a False Discovery
Rate (FDR) adjusted P < 0.05 [29]. Differentially
expressed elements were independently identified for
each cow. In a conservative extension of this analysis, a
subset of the significantly differentially expressed ele-
ments was selected that had: (i) expression data in all test
samples and; (ii) showed at least 2-fold change in expres-
sion in any of the test samples compared to the control
sample. The signal for each of these 183 differentially
expressed elements was then averaged in all cows receiv-
ing the same dose. In this way, gene expression values
were obtained for these genes from the test quarters
infused with S. aureus at dose rates of 500 (n = 1), 10,000
(n = 2), 100,000 (n = 3) or 1,000,000 (n = 2) bacteria rel-
ative to the control quarters. The expression data for these
183 elements were clustered using a K-means algorithm
into 9 clusters using default parameters [30]. The gene
redundancy on the microarray revealed overlap between
several of the clusters. Consequently, these clusters were
manually collapsed into two primary clusters in which the
significantly differentially expressed elements were either
reduced (repressed) or increased (induced) in response to
S. aureus infection (Fig. 3). Each cluster is represented by
the centroid of gene expression for all elements in the
cluster. The 128 elements that showed increased expres-
sion in response to S. aureus challenge are shown in Figure
3(a), while the 55 elements with decreased gene expres-
sion in response to S. aureus are presented in Figure 3(b).
The cluster containing elements that were up-regulated in
response to infection showed increased gene expression
only as the number of infused bacteria reached a thresh-
old dose i.e. the centroid for this cluster showed little
response at a dose up to 10,000 bacteria but a strong and
sustained positive response at higher doses. As expected
from the data, there was substantial variation in the
responses of individual genes at the higher doses (cf Fig.
1). The characteristics of this cluster are exemplified by the
responses of genes such as IL-6, IL-1β and IL-8 (Fig. 1(b)).
The cluster containing down-regulated genes showed sup-
Table 2: Pathology of milk samples 16 h post-infusion
Cow Test Left Fore Right Fore Left Hind Right Hind
#1490 Dose1 PBS  5 × 102 1 × 104 1 × 105
Growth2 Minor8 +++
Gramstain3 -+++
Hemolysis4 - partial partial +
Catalase5 -+++
Coagulase6 -+++
Isolate7 n.d. S. aureus S. aureus S. aureus
#1592 Dose 1 × 104 PBS  1 × 105 1 × 106
Growth + none + +
Gramstain + - + +
Hemolysis partial - partial partial
Catalase + - + +
Coagulase + - + +
Isolate S. aureus none S. aureus S. aureus
#1419 Dose PBS  Nil 1 × 105 1 × 106
Growth none + + +
Gramstain - + + +
Hemolysis - partial partial partial
Catalase - + + +
Coagulase - + + +
Isolate none S. aureus S. aureus S. aureus
1 Bacterial dose
2 Bacterial growth (+/-)
3 Gram positive or Gram negative
4 Hemolysis; hemolytic on blood agar (+, partial, -)
5 Catalase (+/-)
6Coagulase (+/-)
7Bacterial species identified
8 Minor bacterial growth was observed but this was not S. aureus.BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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Relative expression of selected genes in mammary tissue challenged with S. aureus Figure 1
Relative expression of selected genes in mammary tissue challenged with S. aureus. The relative gene expression 
levels of selected genes were measured by qRT-PCR. Samples were obtained from mammary tissues of three Holstein Friesian 
cows at peak lactation 16 hours following intramammary infusion with increasing doses of S. aureus into the separate udder 
quarters. Data for each gene are expressed as relative fold changes compared to expression in the intra-animal control tissue 
for each animal. The genes tested included: (a) α-S1-casein (CSN1S1) (turquoise diamond) and β-casein (CSN2) (red triangle); 
(b) Interleukin 8 (IL-8a) (blue square), Interleukin 1β (IL-1βb) (red diamond), Tumor necrosis factor α (TNFαc) (yellow dia-
mond), Interleukin 6 (IL-6d) (green circle) and CD14 antigen (CD14e) (black triangle); (c) S100 calcium-binding protein A12 
(S100A12f) (blue diamond) and Pentraxin-3 (PTX3g) (pink square). Expression data for each gene were analysed by ANOVA. 
The superscript letters are specific for each gene tested and signify significant differences (P < 0.01) between a specific infection 
dose and the corresponding intramammary control for each cow.
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pression of gene expression compared to the controls at
all bacterial doses, although these effects were not as
marked.
A number of the differentially expressed elements identi-
fied by this analysis were anonymous on the microarray
and consequently inserts from the corresponding cDNA
clones were sequenced and annotated. This process
revealed that the 128 up-regulated elements represented
56 unique transcripts (Table 3) while the 55 down-regu-
lated elements represented 42 unique transcripts (Table
4). This reflected the redundancy of elements on the
microarray and the technical replication of the data. Due
to the biased representation of innate immune genes on
the microarray, a Gene Ontology (GO) analysis was not
performed to identify enriched GO terms. For conven-
ience of presentation and discussion however, the differ-
entially expressed genes were placed in several functional
categories, which were derived by direct examination of
the scientific literature (Tables 3 and 4).
The up-regulated genes were dominated by 22 genes
encoding proteins involved in intercellular signalling.
Many of these were well defined pro-inflammatory
cytokines and chemokines (eg. CXCL1, CXCL2, IFNγ, IL-
6, IL-8 and IL-1β) as well as proteins with less defined
functions but associated with inflammatory responses
(eg. S100A12 and PTX3) [31,32]. Interestingly, this group
of genes also included leptin (LEP), alluding to a link
between infection and energy partitioning in the form of
lipid storage and metabolism [33]. Another group (10
genes) associated with the up-regulated genes was charac-
terised as cell surface receptors. Many of these are inti-
mately associated with the previous functional group. For
example, the Toll-like receptor pathway senses and
responds to bacterial infections through the Toll-like
receptor signalling pathway resulting in stimulation of
synthesis of a number of pro-inflammatory cytokines and
chemokines [34]. This specific pathway is represented by
toll-like receptor 2 (TLR2), toll-like receptor 4 (TLR4) and
CD14 [35,36]. Both TLR2 and TLR4 are membrane-
bound pattern recognition receptors. In addition, the cell
surface receptor group contains TNF receptor superfamily
9 (TNFRSF9) and CD40 antigen (CD40), both of which
are components of the TNF receptor superfamily. The up-
regulation of a group of transcription factors and tran-
scriptional co-regulators (8 genes) may be underlying the
transcriptional changes of other genes in these clusters.
Many of these former genes encode proteins that are piv-
otal regulators of innate immune responsiveness e.g. FOS,
JUN, NF-κB2, NF-κB1A [37]. A small group of genes
involved in apoptosis was also identified.
The cluster containing the down-regulated genes was
dominated by 10 genes encoding proteins which are com-
ponents of the cytoskeleton or extracellular matrix. Thus,
even over the relatively short duration of the infection, the
beginning of a tissue remodelling process may have been
in progress, although this did not adversely affect the tran-
scription of milk protein genes. Other major functional
groups in this cluster included apoptosis (4 genes), cell
surface receptors (7 genes) and intercellular signalling
proteins (6 genes). The latter group encoded a diverse
group of proteins including interleukin 13 (IL-13), which
normally suppresses proinflammatory cytokine produc-
tion [38,39]. Resistin (RETN), another member of this
group, is an adipocyte-secreted protein involved in type II
diabetes and obesity and its identification provides a fur-
ther link between energy metabolism and inflammatory
responses in mammary tissue [40,41]. Somewhat surpris-
ingly, CAMP, which encodes a cathelicidin anti-microbial
peptide, was also in this down-regulated group. Although
the qRT-PCR data indicated no significant change in the
expression of αS1-casein (CSN1S1), the microarray data
included this gene in the list of down-regulated genes. The
reasons for this discrepancy are not clear but could reflect
higher reproducibility of the microarray data relative to
the qRT-PCR data for genes that are highly expressed.
Validation of differentially expressed genes using qRT-PCR
All of the genes, with the exception of CD14 and TNFα,
that were differentially expressed as defined by the initial
qRT-PCR analyses (Fig. 1(b)), were also differentially
expressed when measured by microarray analysis. The rea-
sons why CD14  and  TNFα  were not identified in the
microarray analysis but showed differential expression
Microarray experimental design Figure 2
Microarray experimental design. Gene expression in 
mammary tissue samples from each cow was analysed by 
microarray hybridisation using an 'all-pairs design'. The figure 
is a schematic representation of the microarray design used 
for each cow (except cow 1419 which only had 2 intramam-
mary bacterial infusions), where each arrow represents one 
microarray slide with the direction of the arrow indicating 
the cDNA labelling from Cy5 to Cy3-labelled cDNA.
Control Dose 1
Dose 2 Dose 3BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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when measured by qRT-PCR are not clear but may relate
to the conservative process used in the former analysis and
the differing sensitivities of the two technologies. qRT-
PCR was also used to verify the differential expression of
two additional up-regulated genes, S100A12 (S100 cal-
cium-binding protein A12) and PTX3  (Pentraxin 3)),
identified by the microarray analysis (Fig. 1(c)). Consist-
ent with the general trends in previous data (Fig. 1(b)),
the expression patterns of S100A12 and PTX3 were signif-
icantly up-regulated within each cow but showed varying
responses relative to each intra-animal control. At the
common infection dose of 1 × 105 bacteria for cows 1419,
1490 and 1592, there was 5.2, 36.5 and 49.1 fold up-reg-
ulation of S100A12 expression and 11.1, 9.9 and 19 fold
up-regulation of PTX3 expression, compared to the intra-
animal controls, respectively (all P < 0.01) (Fig. 1(c)).
Expression of S100A12 and PTX3 after stimulation of 
bovine mammary epithelial cells with lipopolysaccharide 
or lipoteichoic acid
The expression levels of S100A12 and PTX3 transcripts in
primary bovine mammary epithelial cells (bMEC) grown
in cell culture were significantly increased in response to
stimulation by 50 μg/ml of lipopolysaccharide (LPS) or
20 μg/ml of lipoteichoic acid (LTA) for a period of 24 h
(Fig. 4). S100A12 was significantly (P < 0.01) up-regu-
lated 4–24 h after LPS stimulation with a maximal fold
change of 10.6 at 24 h. The effect of stimulation with LTA
was less pronounced and resulted in significantly (P <
0.01) increased S100A12  mRNA expression at 8–24 h
post-stimulation with the expression reaching a plateau at
16 h (Fig. 4(a)). PTX3 was up-regulated at 4 h (2.2 fold)
of stimulation with LPS (P < 0.01) but then declined to
basal levels. LTA stimulation resulted in enhanced expres-
sion of PTX3 at 2 h post-stimulation (4.5 fold) (P < 0.01)
but the levels thereafter rapidly declined and at 16 h and
24 h there were significantly (P < 0.01) lower levels of
expression compared to the starting sample (Fig. 4(b)).
Thus, bMEC were likely to be the origin of at least some of
the enhanced expression of S100A12 and PTX3 observed
in mammary tissue challenged with S. aureus. Moreover,
the time course responses for S100A12 and PTX3 were
strikingly different.
Expression and purification of rS100A12 and rPTX3
The coding sequences for bovine S100A12 and the mature
form of bovine PTX3 were amplified by PCR, sequence
verified and cloned into the pQE9 vector. The respective
recombinant proteins, rS100A12 and rPTX3, were solubi-
lised from inclusion bodies using 8 M urea and purified
using Ni-NTA affinity chromatography. SDS-polyacryla-
mide gel analyses confirmed that the purified protein
monomers were of the predicted sizes, i.e. ~11 kDa for
rS100A12 and ~40 kDa for rPTX3 (Fig. 5). The latter pro-
tein was reduced and alkylated before analysis as this was
required to ensure removal of rPTX3 oligomers. N-termi-
nal sequencing further validated the identities of the two
recombinant proteins. These recombinant proteins were
used to raise corresponding polyclonal antibodies in rab-
Clusters of differentially expressed genes in response to  intramammary infusion of S. aureus Figure 3
Clusters of differentially expressed genes in response 
to intramammary infusion of S. aureus. Microarrays 
were performed on tissue from each mammary quarter with 
data compared to the intramammary control for each cow to 
identify differentially expressed transcripts. The figure shows 
the mean gene expression cluster profiles for the significantly 
differentially expressed elements that were either up-regu-
lated (a) or down-regulated (b) relative to the control in 
response to intramammary infusion of S. aureus. The clusters 
only contain significantly differentially expressed elements 
that were expressed in all samples and showed at least 2 fold 
change relative to the control in at least one sample. RNA 
samples were obtained from mammary tissue of three Hol-
stein Friesian cows at peak lactation that had been infused 
with pyrogen-free PBS (dose 0, n = 3) in one quarter (intra-
animal controls) and in other quarters with S. aureus at dose 
rates of 500 (n = 1), 10,000 (n = 2), 100,000 (n = 3) or 
1,000,000 (n = 2) bacteria. Data are expressed as log2 (fold 
change) ± 1 S.D. for the centroid of the cluster.
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Table 3: Significantly up-regulated genes in mammary tissue challenged with S. aureus.
Function Gene symbol Genbank accession Genbank description
Chemokine, cytokine and intercellular signalling
CCL11 NM_002986 Homo sapiens chemokine (C-C motif) ligand 11 
(CCL11), mRNA
CCL2 NM_174006 Bos taurus chemokine (C-C motif) ligand 2 (CCL2), 
mRNA.
CCL20 NM_004591 Homo sapiens chemokine (C-C motif) ligand 20 
(CCL20), mRNA
CCL3L1 NM_021006 Homo sapiens chemokine (C-C motif) ligand 3-like 1 
(CCL3L1), mRNA
CCL4L1 AY575854 Homo sapiens similar to cytokine (LOC388372), 
mRNA
CSF3 NM_172219 Homo sapiens colony stimulating factor 3 
(granulocyte) (CSF3), transcript variant 2, mRNA
CXCL1 NM_001511 Homo sapiens chemokine (C-X-C motif) ligand 1 
(melanoma growth stimulating activity,
CXCL2 NM_002089 Homo sapiens chemokine (C-X-C motif) ligand 2 
(CXCL2), mRNA
CXCL10 AB070717 Homo sapiens chemokine (C-X-C motif) ligand 10 
(CXCL10), mRNA
IL1B NM_174093 Bos taurus interleukin 1, beta (IL1B), mRNA.
IL6 NM_001009392 Ovis aries interleukin 6 (IL6), mRNA
IFNG NM_174086 interferon-gamma; Bos taurus interferon, gamma or 
immune type [interferon gamma type 2]
IL8 NM_173925 Bos taurus interleukin 8 [neutrophil activating 
peptide 1] (IL8), mRNA.
LEP NM_173928 Bos taurus leptin [obesity] (LEP), mRNA
PLAUR NM_174423.2 Homo sapiens plasminogen activator, urokinase 
receptor (PLAUR), mRNA
PTX3 NM_002852 Homo sapiens pentaxin-related gene, rapidly induced 
by IL-1 beta (PTX3), mRNA
S100A12 NM_174651 Bos taurus S100 calcium binding protein A12 
(calgranulin C) (S100A12), mRNA
S100A2 NM_005978 Homo sapiens S100 calcium binding protein A2 
(S100A2), mRNA
THBS1 NM_174196 Homo sapiens thrombospondin 1 (THBS1), mRNA
Cell surface receptors
CCR1 NM_001295 Homo sapiens chemokine (C-C motif) receptor 1 
(CCR1), mRNA
CD14 NM_000591 Homo sapiens CD14 antigen (CD14), mRNA
CD40 NM_152854 Homo sapiens tumor necrosis factor receptor 
superfamily, member 5 (TNFRSF5), transcript
CSF3R NM_172313 Homo sapiens colony stimulating factor 3 receptor 
(granulocyte) (CSF3R), transcript variant
IL11RA NM_147162 Homo sapiens interleukin 11 receptor, alpha 
(IL11RA), transcript variant 2, mRNA
SLC2A4 NM_001042 Homo sapiens solute carrier family 2 (facilitated 
glucose transporter), member 4 (SLC2A4)
TLR2 NM_003264 Homo sapiens toll-like receptor 2 (TLR2), mRNA
TLR4 NM_138557 Homo sapiens toll-like receptor 4 (TLR4), transcript 
variant 4, mRNA
TNFRSF9 NM_001561 Homo sapiens tumor necrosis factor receptor 
superfamily, member 9 (TNFRSF9), mRNA
Intracellular signaling
CDKN1A NM_078467 Homo sapiens cyclin-dependent kinase inhibitor 1A 
(p21, Cip1) (CDKN1A), transcript variant 2, mRNA
FGD6 AC009159 Homo sapiens FYVE, RhoGEF and PH domain 
containing 6 (FGD6), mRNA
MTMR10 AJ567991 Homo sapiens hypothetical protein FLJ20313 
(FLJ20313), mRNABMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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bits, which were used to test whether S100A12 and PTX3
were present in milk samples from infected cows.
Identification of S100A12 and PTX3 in milk from cows with 
intramammary S. aureus infection
Figure 6 shows immunoblots of milk whey taken from
control udder quarters or udder quarters infected with S.
aureus at doses of 1 × 105 and 1 × 106 bacteria for 16 h. The
antibodies used were immunoaffinity-purified antibodies
raised to purified rS100A12 or rPTX3. In each case there
was little or no detectable immunoreactivity in the milk
whey samples from the uninfected controls or samples
from udder quarters taken prior to the experimental infec-
tions. S100A12 and PTX3 immunoreactive bands were
HCK NM_002110 Homo sapiens hemopoietic cell kinase (HCK), 
mRNA
MARCKS NM_002356 Homo sapiens myristoylated alanine-rich protein 
kinase C substrate (MARCKS), mRNA
MARCKSL1 NM_023009 Homo sapiens MARCKS-like protein (MLP), mRNA
ZFYVE9 NM_007324 Homo sapiens MAD, mothers against 
decapentaplegic homolog (Drosophila) interacting
Apoptosis
BAT3 NM_174196 Homo sapiens HLA-B associated transcript 3 (BAT3), 
transcript variant 3, mRNA
BCL2A1 NP_004040 Homo sapiens BCL2-related protein A1 (BCL2A1), 
mRNA
BIRC3 NM_182962 Homo sapiens baculoviral IAP repeat-containing 3 
(BIRC3), transcript variant 2, mRNA
IER3 NM_003897 Homo sapiens immediate early response 3 (IER3), 
transcript variant short, mRNA
Transcription factor or regulator
ATF3 NM_001674 Homo sapiens activating transcription factor 3 
(ATF3), mRNA
BTG2 NM_006763 Homo sapiens BTG family, member 2 (BTG2), 
mRNA
EGR1 NM_001964 Homo sapiens early growth response 1 (EGR1), 
mRNA
FOS NM_005252 Homo sapiens v-fos FBJ murine osteosarcoma viral 
oncogene homolog (FOS), mRNA
JUNB NM_002229 Homo sapiens jun B proto-oncogene (JUNB), mRNA
NFKB2 NM_002502 Homo sapiens nuclear factor of kappa light 
polypeptide gene enhancer in B-cells
NFKBIA NM_020529 Homo sapiens nuclear factor of kappa light 
polypeptide gene enhancer in B-cells inhibitor
NR2F6 AF338825 Homo sapiens nuclear receptor subfamily 2, group F, 
member 6 (NR2F6), mRNA
Assorted
ACSL6 NM_015256 Homo sapiens acyl-CoA synthetase long-chain family 
member 6 (ACSL6), mRNA
FUT8 NM_177501 Homo sapiens fucosyltransferase 8 (alpha (1,6) 
fucosyltransferase) (FUT8), transcript
HSPA1A NM_005345 Homo sapiens heat shock 70 kDa protein 1A 
(HSPA1A), mRNA
MGC21881 XP_219130 Homo sapiens hypothetical protein LOC286286 
(LOC286286), mRNA
NOS2A NM_000625 Homo sapiens nitric oxide synthase 2A (inducible, 
hepatocytes) (NOS2A), transcript variant
SOD2 L22092 Homo sapiens superoxide dismutase 2, 
mitochondrial (SOD2), mRNA
TIMP1 NM_003254 Homo sapiens tissue inhibitor of metalloproteinase 1 
(erythroid potentiating activity, collagenase)
TUBA1 NM_006000 Homo sapiens tubulin, alpha 1 (testis specific) 
(TUBA1), mRNA
WARS NM_174218 Homo sapiens tryptophanyl-tRNA synthetase 
(WARS), mRNA
Table 3: Significantly up-regulated genes in mammary tissue challenged with S. aureus. (Continued)BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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Table 4: Significantly down-regulated genes in mammary tissue challenged with S. aureus.
Function Gene symbol Genbank accession Genbank description
Chemokine, cytokine and 
intercellular signalling
IL1A M37210 Bovine interleukin 1-alpha (IL-1-alpha) mRNA, complete cds.
NGFB NM_002506 Homo sapiens nerve growth factor, beta polypeptide (NGFB), 
mRNA
IL13 AF072807 Bos taurus interleukin-13 precursor (IL-13) mRNA, partial cds
RETN NM_183362 Bos taurus resistin (RETN), mRNA
SFRP1 NM_003012 Homo sapiens secreted frizzled-related protein 1 (SFRP1), 
mRNA
SPP1 AF492837 Homo sapiens secreted phosphoprotein 1 (osteopontin, bone 
sialoprotein I, early T-lymphocyte activation 1) (SPP1), mRNA
Cytoskeleton and extracellular 
matrix
CD24 NM_013230 Homo sapiens CD24 antigen (small cell lung carcinoma cluster 
4 antigen) (CD24),
EPB41L1 NM_174528 Homo sapiens erythrocyte membrane protein band 4.1-like 1 
(EPB41L1), transcript
FLNA NM_001456 Homo sapiens filamin A, alpha (actin binding protein 280) 
(FLNA), mRNA
ITGA3 NM_002204 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 
subunit of VLA-3 receptor
ITGB4 NM_000213 Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral 
oncogene homolog
KRT5 BC006780 Homo sapiens keratin 5 (epidermolysis bullosa simplex, 
Dowling-Meara/Kobner/Weber
PFN2 NM_053024 Homo sapiens profilin 2 (PFN2), transcript variant 1, mRNA
VCAM1 NM_174484 Homo sapiens vascular cell adhesion molecule 1 (VCAM1), 
transcript variant 2, mRNA
VCL NM_014000 Homo sapiens vinculin (VCL), transcript variant meta-VCL, 
mRNA
VIM NM_003380 Homo sapiens vimentin (VIM), mRNA
Cell surface receptors
CX3CR1 NM_001337 Homo sapiens chemokine (C-X3-C motif) receptor 1 
(CX3CR1), mRNA
ERBB4 NM_005235 Homo sapiens v-erb-a erythroblastic leukemia viral oncogene 
homolog 4 (avian)
FGFR1 NM_023106 Homo sapiens fibroblast growth factor receptor 1 (fms-related 
tyrosine kinase 2)
KIT NM_000222 Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral 
oncogene homolog (KIT)
MET V00654 Homo sapiens met proto-oncogene (hepatocyte growth factor 
receptor) (MET), mRNA
PDGFRA NM_006206 Homo sapiens platelet-derived growth factor receptor, alpha 
polypeptide (PDGFRA)
TGFBR3 NM_003243 Homo sapiens transforming growth factor, beta receptor III 
(betaglycan, 300 kDa)
Intracellular signaling
PP M95283 Homo sapiens pyrophosphatase (inorganic) (PP), mRNA
PPM1J NM_005167 Homo sapiens protein phosphatase 1J (PP2C domain 
containing) (PPM1J), mRNA
PRKCA NM_174435 Homo sapiens protein kinase C, alpha (PRKCA), mRNA
RHOB NM_004040 Homo sapiens ras homolog gene family, member B (RHOB), 
mRNA
Apoptosis
CIDEA NM_001279 Homo sapiens cell death-inducing DFFA-like effector a 
(CIDEA), transcript variant
CLU NM_173902 Bos taurus clusterin (CLU), mRNA.
EPHA1 NM_005232 Homo sapiens EphA1 (EPHA1), mRNABMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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identified in all samples obtained from the infected quar-
ters of the three tested cows. For cow 1419, three S100A12
immunoreactive bands were detected corresponding to
monomer (Mr ~11 kDa), dimer (Mr ~22 kDa) and trimer
(Mr ~33 kDa), despite the sample being reduced (Fig.
6(a)). The predicted size of bovine S100A12 is 10.7 kDa.
The dimeric form was predominant. Human S100A12
exists as a highly stable dimer [42]. Similar results were
also obtained for milk samples from cows 1490 and 1592.
For PTX3, the predominant immunoreactive band was the
dimeric form of PTX3 (Mr ~90 kDa), again despite the
sample being run under reducing conditions. Monomeric
PTX3 (Mr ~45 kDa) was also discernable (Fig. 6(b)). The
predicted Mw of the mature PTX3 protein is 40.2 kDa. The
bovine PTX3 predicted amino acid sequence contains one
potential N-linked glycosylation site (Asn221) and indeed
this type of glycosylation is present on the PTX3 protein
derived from other species [43]. Close examination of the
dimeric immunoreactive band reveals micro-heterogene-
ity that could reflect differential glycosylation or the for-
mation of mixed intramolecular disulphide bonds. The
latter could result from re-oxidation of cysteine residues
during the electrophoretic separation process. For cow
1419 the immunoreactive bands were more intense at the
bacterial dose of 1 × 106 compared to 1 × 105. This result
was consistent with the corresponding transcriptional
changes (Fig. 1(c)) and measurements of the quantities of
this protein in milk whey samples using an antigen cap-
ture ELISA (see below). The absence of S100A12 and PTX3
immunoreactivities in milk from both the control udder
quarter and the pre-infection samples from cow 1419
indicates that the low level S. aureus infection detected in
one (unused) udder quarter of this cow 24 h prior to the
commencement of the experimental infection had not
influenced the remaining quarters. Further, these data
indicate that the experimental infection in one quarter did
not influence the adjacent control udder quarter under
these conditions.
Quantification of S100A12 and PTX3 proteins in milk from 
cows subjected to intramammary infection with S. aureus
Antigen specific enzyme-linked immunosorbent assays
(ELISAs) were developed to measure the quantities of
S100A12 and PTX3 in milk samples taken from udder
quarters after S. aureus intramammary challenges of the
three cows (Fig. 7). Significantly increased S100A12 pro-
tein expression (P < 0.01) was detected in the milk whey
from the infected udders in all three cows relative to their
respective intramammary control quarters (at 16 h post-
infection). There was a low level of S100A12 expression in
milk samples from the control non-infected udders.
Moreover, there was a relatively small but significantly (P
< 0.01) higher level of S100A12 in milk from the control
udder quarters 16 h post-infection compared with the cor-
responding pre-infection samples. Thus, using this anti-
gen capture ELISA there was evidence for a small
intermammary quarter effect on S100A12 levels in milk.
The responses to infection in the different cows were var-
ied. Cow 1419 had a concentration of 420 ng/ml of
S100A12 in milk from the control udder at 16 h post-
infection while the S100A12 levels in the udders that had
been challenged with 1 × 105 and 1 × 106 bacteria were
almost five times greater (1920 ng/ml in the milk from
both udder quarters) (P < 0.01). Cow 1490 had lower lev-
els of S100A12 in the control udder (90 ng/ml) and the
EPHA7 NM_004440 Homo sapiens EphA7 (EPHA7), mRNA
Transcription factor or regulator
DDX5 NM_004396 Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 
(DDX5), mRNA
NFATC4 NM_004554 Homo sapiens nuclear factor of activated T-cells, cytoplasmic, 
calcineurin-dependent
TEBP NM_006601 Homo sapiens inactive progesterone receptor, 23 kD (TEBP), 
mRNA
Assorted
CAMP NM_174825 Homo sapiens cathelicidin antimicrobial peptide (CAMP), 
mRNA
CSN1S1 NM_181029 Homo sapiens casein alpha s1 (CSN1S1), mRNA
FLJ20920 NM_025149 Homo sapiens hypothetical protein FLJ20920 (FLJ20920), 
mRNA
GATM NM_001482 Homo sapiens glycine amidinotransferase (L-arginine:glycine 
amidinotransferase
GPX4 NM_002085 Homo sapiens glutathione peroxidase 4 (phospholipid 
hydroperoxidase) (GPX4)
LOC529035 AF109167 Bos taurus immunoglobulin IgA heavy chain constant region 
gene, partial cds
18S rRNA AY150548 Cervus nippon 18S ribosomal RNA gene, partial sequence
SNX19 AC150499 Homo sapiens similar to Sorting nexin 19 (LOC399979), 
mRNA
Table 4: Significantly down-regulated genes in mammary tissue challenged with S. aureus. (Continued)BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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levels of S100A12 increased in a dose-dependent manner
(P < 0.01). The S100A12 protein expression was relatively
high in milk from udder quarters infected with bacterial
doses of 1 × 105 and 1 × 106 in cow 1592 (918 ng/ml and
1000 ng/ml, respectively) (P < 0.01) while the quantities
of S100A12 detected in milk from the udder quarter chal-
lenged with the lowest dose of 1 × 104 bacteria (140 ng/
ml) was not significantly different from the control udder
(150 ng/ml).
Increased concentrations of PTX3 were detected in milk
whey from the infected udders in all three cows compared
to their intramammary quarters (Fig. 7(b)). PTX3 could
not be detected in milk from the pre-infection udders or
the post-infection control udders. Cow 1419 showed the
highest levels of PTX3 in milk from the udder quarters
that had been challenged with 1 × 105 and 1 × 106 bacteria
(4.6 μg/ml and 14.2 μg/ml, respectively). Cow 1490 had
less marked, but still significantly (P < 0.01) increased lev-
els of PTX3 in response to the bacterial dose of 1 × 105 (i.e.
3 μg/ml). The quantities of PTX3 detected in milk from
the udder quarters of cow 1592 challenged with the two
higher bacterial doses, 1 × 105 and 1 × 106 of S. aureus,
were significantly (P < 0.01) increased (i.e. 2.7 μg/ml and
1.6 μg/ml respectively).
Correlation between the Somatic Cell Count (SCC) and 
S100A12 protein expression in milk from dairy cows
The S100A12 protein levels in milk were measured using
the S100A12-specific antigen capture ELISA and corre-
lated with the milk somatic cell count (SCC) from a selec-
tion of 38 dairy cows with SCC ranging from 1 × 104 – 3 ×
106  cells/ml (Fig. 8). There was a linear correlation
between S100A12 quantity in milk and milk SCC (R2 =
0.92). The PTX3-specific antigen capture ELISA was not
used to examine the correlation between PTX3 quantity in
milk and SCC due to the relatively low levels of PTX3
present in all milk samples.
Recombinant S100A12 has anti-microbial activity against 
E. coli
A previous publication suggested that human S100A12
may have anti-microbial activity [44]. The capacity of
recombinant bovine S100A12 (rS100A12) to inhibit E.
coli growth was examined using a microtiter dilution anti-
microbial susceptibility testing assay [45]. Inhibition of
growth of E. coli (strain LE392) was observed in the
rS100A12 concentration range of 12.5–50 μg/ml (P <
0.05) (Fig. 9(a)). The greatest inhibitory activity was
observed using 25 μg/ml of rS100A12, which resulted in a
2.3 fold reduction in optical density of the E. coli culture.
Under the same conditions rS100A12 did not signifi-
cantly (P > 0.05) affect the growth of S. aureus (ATCC
25923) at any concentration (Fig. 9(b)).
Expression of recombinant bovine PTX3 in Trichoplusia ni 
insect cells
Recombinant bovine PTX3 (rtnPTX3) was also produced
in insect cells to obtain a correctly folded and biologically
active protein. The culture supernatant from the Trichoplu-
sia ni (High Five™) insect cells transfected with the pIEX5-
PTX3 construct was analysed by SDS-PAGE and immuno-
bloting under reducing conditions. Immunoreactive pro-
Time-courses of S100A12 and PTX3 expression in bMEC  stimulated with LPS and LTA Figure 4
Time-courses of S100A12 and PTX3 expression in 
bMEC stimulated with LPS and LTA. bMEC were stim-
ulated with either 50 μg/ml LPS (n) or 20 μg/ml LTA () and 
the expression levels of S100A12 (a) and PTX3 (b) were 
monitored using qRT-PCR over a 24 h period. Data are 
expressed as mean fold change (n = 3) compared to expres-
sion in unstimulated cells. Significance was determined by 
ANOVA compared to unstimulated bMEC. P < 0.01 (*) was 
considered significant.
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teins with an apparent molecular size of 45 kDa
(monomer) and 90 kDa (dimer) were present but not
observed in the culture supernatant from the plasmid-
only control (results not shown). rtnPTX3 produced by
these cells was purified from the culture supernatant using
anion exchange chromatography. Figure 5(c) shows sil-
ver-stained SDS-PAGE and immunoblot analyses of puri-
fied rtnPTX3 after reduction and alkylation. The purified
protein was represented by two equal staining bands of
Mr 43 kDa and 45 kDa compared with a predicted size for
the mature protein of 40.2 kDa. The PTX3 sequence has a
potential N-linked glycosylation site at amino acid posi-
tion 221 (N221) and hence the larger band may reflect a
more glycosylated form of the protein. N-terminal
sequencing of rtnPTX3, from both bands, showed identity
with the predicted amino acid sequence of the mature
bovine PTX3 polypeptide (GenPept accession AAI20176).
The mature PTX3 protein sequence contains nine cysteine
residues, which may mediate formation of multimers
[43]. Indeed, rtnPTX3 was present in solution as a large
oligomer (decamer) as defined by gel permeation chro-
matography (result not shown).
Purified rtnPTX3 binds the C1q component of the human 
complement system
The binding of human PTX3 expressed in Chinese Ham-
ster Ovary (CHO) cells to human C1q has been previously
demonstrated [43,46]. To characterise the binding of
rtnPTX3 to C1q, dilutions of two different preparations of
purified rtnPTX3 were added to 500 ng of immobilised
human C1q and after washing bound rtnPTX3 was meas-
ured. Figure 10 demonstrates that rtnPTX3 bound to
human C1q compared to either the BSA or PBS control
(Fig. 10).
rtnPTX3 binds E. coli
rtnPTX3 was tested for ability to inhibit the growth of E.
coli (strain LE392) or S. aureus (ATCC 25923) using the
assay described for rS100A12. No direct activity could be
demonstrated. However, it has been reported that human
PTX3 binds selected pathogens including Pseudomonas
aeruginosa, Salmonella typhimurium and Aspergillus fumiga-
tus [47]. To investigate the possibility that bovine rtnPTX3
binds E. coli, the protein was bound to nitrocellulose in a
slot blot and then probed with biotinylated E. coli. The
slot blot showed that biotinylated E. coli in PBS bound to
rtnPTX3 but not the same quantity of BSA (Fig. 11). Bioti-
nylated S. aureus (1 × 109 bacteria) in PBS did not bind to
the immobilised rtnPTX3 (result not shown).
Discussion
The objective of this study was to characterise the host
transcriptional response to intra-mammary infection with
S. aureus, a Gram-positive bacterial pathogen. We initially
investigated the mRNA expression levels of two major
milk protein genes (CSN1S1 and CSN2) in the udder tis-
sue to confirm that transcripts encoding proteins involved
in the major physiological function of the udder, milk
protein production, were not affected by the experimental
infection. These qRT-PCR measurements demonstrated
that the limited experimental infection, in terms of infec-
tion time and dose, had not caused significant loss of
function in the mammary tissue. Thus, the experimental
model measured changes in immune gene responses that
are likely to be appropriate for the initial stages of infec-
tion.
Transcript profiling was employed to analyse gene expres-
sion in mammary tissue challenged by S. aureus infection.
Initially, mRNA levels of a number of genes (CD14, IL-1β,
IL-6, IL-8 and TNFα), principally encoding proinflamma-
tory cytokines, were measured. These genes showed signif-
icant dose-dependent up-regulation in all three cows
subjected to intramammary infusion with S. aureus for a
16 h period. The dose dependent transcriptional
responses probably directly reflect the dose of bacteria in
the tissue and also, due to the lag phase in bacterial
growth, different durations of inflammation in the tissue.
Purified S100A12 and PTX3 recombinant proteins Figure 5
Purified S100A12 and PTX3 recombinant proteins. 
(a) SDS-PAGE analysis of rS100A12 purified using Ni-NTA 
affinity chromatography. All samples were run under reduc-
ing conditions. Lanes 1–4: 1, 2.5, 5 and 12.5 μg of rS100A12, 
respectively. (b) SDS-PAGE analysis of rPTX3 purified using 
Ni-NTA affinity chromatography. The samples were reduced 
and alkylated, and run under reducing conditions. Lanes 1–3: 
1, 2 and 4 μg of rPTX3, respectively. (c) SDS-PAGE (lane 1) 
and immunoblot (lane 2) analyses of purified rtnPTX3 
secreted by Trichoplusia ni cells. The samples were reduced 
and alkylated and run under reducing conditions. 10 μg of 
rtnPTX3 was used for the SDS-PAGE analysis and 5 μg for 
the immunoblot.
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This experiment also demonstrated that S. aureus
intramammary infusion had generated an immune
response that was self-contained within each udder quar-
ter i.e. the experimental infection in one udder quarter did
not affect gene expression in the adjacent control udder
quarter. Although TNFα mRNA, measured by qRT-PCR,
was up-regulated by the intramammary infusion of S.
aureus, it has been reported that the protein was not
detectable in milk from udders infected with S. aureus
[48,49]. One possible explanation is that this apparent
disparity reflects the differing sensitivities and dynamic
ranges of the measurement technologies. Another possi-
bility is that the observed changes in mRNA expression for
TNFα do not accurately translate into corresponding
secreted protein changes. This could occur when mRNA
translation or protein secretion were rate limiting in defin-
ing the quantity of TNFα in milk.
The reasons for the more accentuated responses in cow
1419 are not clear but may reflect differing genetics under-
lying individual immune responsiveness or a different
history of disease exposure. It is also possible that cow
1419 had been primed for a stronger innate immune
response as a result of a low level of asymptomatic pre-
existing infection in one quarter prior to the experimental
challenge, despite this quarter not being used in the exper-
iment. However, the control quarter from this cow did not
display increased expression of TNFα or IL-8 relative to
the controls from the other two cows, indicating that
expression of genes in the control quarter from cow 1419
was not systemically affected by a pre-existing mild infec-
tion in the unused adjacent quarter. Another possibility is
that the infection was not uniform in the udder quarter
and sampling had occurred in regions from this animal
that had a greater extent of infection.
Immunoblot analyses of S100A12 and PTX3 expression in milk whey from S. aureus infected cattle Figure 6
Immunoblot analyses of S100A12 and PTX3 expression in milk whey from S. aureus infected cattle. Representa-
tive immunoblot analyses of milk whey proteins before and after infection of mammary tissue with S. aureus. Each sample com-
prised 25 μl of milk whey and was run under reducing conditions. (a) Representative analysis of S100A12 expression in milk 
whey from cow 1419. Lane 1, control quarter pre-infection; lane 2, control quarter post-infection; lane 3, pre-infection control 
from the quarter receiving 1 × 105 S. aureus; lane 4, post-infection sample (1 × 105 bacteria); lane 5, pre-infection control from 
the quarter receiving 1 × 106 S. aureus; lane 6, post-infection sample (1 × 106 bacteria). Arrows denote the positions of 
S100A12 immunoreactive oligomers (monomer, dimer, trimer) detected using the immunoaffinity purified antibodies raised to 
rS100A12. (b) Analysis of PTX3 expression in milk whey. Lane 1, cow 1419 pre-infection sample from the quarter receiving 1 
× 105 S. aureus; lane 2, post-infection sample (1 × 105 bacteria); lane 3, cow 1419 pre-infection sample from the quarter receiv-
ing 1 × 106 S. aureus; lane 4, cow 1419 post-infection sample (1 × 106 bacteria); lane 5, cow 1490 pre-infection sample from the 
quarter receiving 1 × 105 S. aureus; lane 6, cow 1490 post-infection sample (1 × 105 bacteria); lane 7, cow 1592 pre-infection 
control from the quarter receiving 1 × 105 S. aureus; lane 8, cow 1592 post-infection sample (1 × 105 bacteria). Arrows denote 
the positions of PTX3 immunoreactive bands (monomer and dimer) detected using immunoaffinity purified antibodies raised to 
rPTX3.
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Previous studies have clearly demonstrated that mam-
mary epithelial cells have a robust innate immune capa-
bility and thus the observed responses in infected
mammary tissue probably reflect transcriptional changes
in these cells as well as cellularity changes caused by infil-
trating immune cells [12]. It might be expected that the
predominant responses would be from the mammary epi-
thelial cells at low infection rates and infiltrating immune
cells at the higher doses as they respond to proinflamma-
tory signals generated by the former cells. The relative dis-
section of these contributions awaits further investigation
possibly involving immunolocalizations or in situ mRNA
localizations.
Microarray transcript profiling identified two major clus-
ters of differentially expressed genes: genes that were up-
regulated and down-regulated after infusion of S. aureus
into the mammary gland. The majority of the up-regu-
lated genes encoded proteins involved in intercellular sig-
nalling and a large number of them were cytokines and
chemokines (e.g. CXCL1, CXCL2, CXCL10, IL-1β, IL-6
and IL-8). These proteins are intimately associated with
inflammatory processes and are probably essential for the
recruitment and activation of neutrophils into the
infected mammary tissue [12,27,50]. The overflow of
these cells into milk is a widely used marker of mastitis in
dairy cows. The down-regulated genes encoded compo-
nents of the cytoskeleton or extracellular matrix, media-
tors of apoptosis, cell surface receptors and intercellular
signalling proteins. The former group suggests that tissue
remodelling of the mammary tissue in response to infec-
tion was beginning to occur despite the maintenance of
normal milk protein gene expression.
The up-regulated cluster also contained genes encoding
proteins with less defined functions. Two such genes,
S100A12 and PTX3, were investigated in greater detail as
they have been previously implicated in inflammatory
responses [51,52] although their specific roles particularly
in relation to bovine mammary tissue have not been
defined. S100A12 and PTX3 mRNAs were markedly up-
regulated in bMEC stimulated with LPS and LTA indicat-
ing that they may be involved in the initial response of
mammary tissue to bacterial infection. However, the time
courses of their responses were very different with PTX3
showing earlier up-regulation but unlike S100A12 it did
not show a sustained response. Thus, the time course
responses of these two genes to the infection were dissim-
ilar.
The S100A12 protein (also known as calgranulin C) trig-
gers a signal transduction cascade that results in activation
of the transcriptional co-regulator NF-κB and consequent
expression of pro-inflammatory cytokines [32,53].
Increased expression of S100A12 in bMEC could amplify
the pro-inflammatory response in infected mammary tis-
sue and thereby promote the infiltration of neutrophils
into the tissue. S100A12 is a small (92 amino acids) cal-
cium-binding protein. Interestingly, its mRNA sequence
does not encode a signal sequence even though the pro-
tein is present externally to stimulated cells and there is a
cell surface receptor, Receptor for Advanced Glycation
End products (RAGE), for S100A12 on the surface of
many cells [32]. One possibility is that S100A12 is
released from cells by an undefined secretory mechanism.
Another possibility is that it is released from cells under-
going inflammation-induced cell death. The interaction
between S100A12 and RAGE is thought to amplify and
propagate the inflammatory response in endothelial cells
through increased NF-κB activation and expression of
pro-inflammatory cytokines. Blockage of this interaction
dampens the response by inhibiting the nuclear transloca-
tion of NF-κB [42]. RAGE is a multi-ligand member of the
immunoglobulin superfamily of cell surface molecules
that binds to Advanced Glycation End products (AGEs),
proinflammatory cytokine-like mediators of the S100/cal-
granulin family, as well as amphoterin and amyloid-β-
protein [54]. The presence and distribution of RAGE in
mammary tissue is unknown.
S100A12 was present in milk samples from S. aureus-
infected udder quarters and the level of the protein was
dependent on the severity of infection. Relatively low
quantities of S100A12 were also found in the milk sam-
ples taken prior to the S. aureus challenge. Interestingly,
using an antigen capture ELISA it was demonstrated that
S100A12 levels in milk samples from the control udder
quarters at 16 h post-infection showed a small but signif-
icant increase compared to the pre-infection control sam-
ples. Thus, there was a small intermammary quarter effect
of the infection but this was minor compared to the
responses in the infected quarters. In a dairy herd there
was significant correlation between the level of milk
S100A12 and SCC, a widely accepted indicator of mastitis.
Thus, S100A12 protein levels in milk could be used as an
indicator of mastitis in dairy cattle.
The current study has also demonstrated that rS100A12
inhibited the growth of E. coli but not S. aureus in a dose-
dependent manner (Fig. 9). This novel finding suggests
that S100A12 may have a direct role in protecting mam-
mary tissue from infection by coliform bacteria and may
play a role in protecting newborn suckling calves from
bacterial infections. The detailed nature of this inhibitory
activity is yet to be defined. The result is somewhat para-
doxical in view of the up-regulation of the expression of
this gene in bMEC stimulated with LTA, a Gram positive
bacterial cell wall component as well as LPS, a Gram neg-
ative bacterial cell wall component.BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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The long pentraxin, PTX3, is a secreted multimeric glyco-
protein that is thought to activate the immune system by
directly binding selected micro-organisms and C1q, the
first component of the classical pathway of complement
activation [43,47]. Indeed, PTX3 is a secreted pattern rec-
ognition receptor. The expression of bovine PTX3 mRNA
was strongly and rapidly up-regulated in bMEC chal-
lenged with LPS and LTA and increased in mammary tis-
sue from udders infected with S. aureus. Thus, PTX3 has
the characteristics of an innate immune protein. Although
no direct anti-bacterial activity could be demonstrated,
rtnPTX3 protein was able to directly bind E. coli. This
result is consistent with a pattern recognition function of
PTX3 that facilitates the immobilisation and display of
micro-organisms. The decameric structure of PTX3, partic-
ularly its disulphide bonded structure, is thought to
underpin this activity [31,43]. The bovine recombinant
protein also underwent oligomerisation (results not
shown). In addition, the current study demonstrated that
recombinant bovine PTX3 bound human C1q, thereby
physically linking the complement system with PTX3-
bound bacteria, presumably promoting opsomization of
the bacteria. At peak lactation only the alternative comple-
ment pathway is active in milk due the absence of C1q.
Therefore the actions of PTX3 probably operate only after
inflammatory exudation of plasma components into milk
[55]. The relatively rapid transcriptional response of
bMEC to LTA is consistent with the view that PTX3 is a
component of the immediate early response, where it acts
to initially bind and coat bacteria, and subsequently acti-
vates the classical pathway of the complement system.
Conclusion
Bovine S100A12 probably amplifies the inflammatory
response via recruitment of neutrophils while bovine
PTX3 activates the immune system by binding to C1q and
selected pathogens. Acting in concert, these proteins are
likely to be important components of a multi-faceted
response of mammary tissue to infection. These proteins
may lead to novel therapeutic strategies for the treatment
and prevention of mastitis. Since S100A12 and PTX3 dis-
play microbial growth inhibition and binding properties,
respectively, they could provide a new class of natural
anti-microbial agents that could assist defense of the
mammary gland against chronic and subclinical infec-
tions. The presence of these innate immune signalling
proteins, amongst other cytokines, in milk may also be
instructive for the maturation of the neonatal immune
system and gut epithelium as well as influencing micro-
bial colonisation of the neonatal gut.
Methods
Cows
Three multiparous Holstein Friesian cows at the peak of
their third or fourth lactation cycles and approximately 21
days post parturition were used. These cows had the fol-
lowing characteristics: Australian Breed Value (ABV) in
the top 25% ; lactation 5,500–9000 L/year; no history of
clinical mastitis; SCCs < 200,000 cells/ml; and Johne's
disease free. Each cow represented a different sire line and
was fed and housed according to standard operating pro-
cedures at the Camden Campus, University of Sydney.
None of the cows had any clinical signs of mastitis in any
quarter prior to the experiment (i.e. no swelling, no overt
signs of pain after prodding the udder, no redness, no
clots in their milk, SCCs < 200,000 cells/ml, no bacterial
growth in milk samples). Animal experiments were per-
formed in accordance with Australian Animal Ethics
Guidelines and with approval from the Faculty of Veteri-
nary Science Animal Ethics Committee, University of Syd-
S100A12 and PTX3 expression in milk from S. aureus  infected cattle Figure 7
S100A12 and PTX3 expression in milk from S. aureus 
infected cattle. Antigen capture ELISAs were used to 
measure the concentrations of S100A12 (a) and PTX3 (b) in 
milk samples taken before and 16 h after the S. aureus 
intramammary challenge. Data from cows 1419, 1490 and 
1592 were used in the analyses. Bars represent the means ± 
SEM for two independent samples. The asterisk denotes sig-
nificant expression difference (1 way ANOVA, P < 0.01) 
compared with the corresponding post-infection control 
sample for each cow. No PTX3 expression could be 
detected in milk from the intra-animal control udders or in 
the pre-infection samples.
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ney (N00/10-2003/2/3829: Collection of Mammary
Biopsies for Dairy Cattle: the Induction of Mastitis).
S. aureus strain
An isolate of the virulent S. aureus strain, JG-80 [56],
derived from a clinical case of ovine mastitis was grown
overnight at 37°C in nutrient broth (BO0759Z; Oxoid).
Bacteria were pelleted (3,600 × g, 4°C, 15 min) and
washed in 20 ml of pyrogen-free PBS (×3). The bacterial
concentration was estimated using the conversion ratio:
OD600 of 0.46 equals 1 × 109 bacteria/ml [57]. Bacterial
cultures were adjusted to the desired concentration by
dilution in 5 ml of pyrogen-free PBS.
S. aureus intramammary challenge and mammary tissue 
collection
The udders of the cows were determined to be free of bac-
teria by assaying a 10 ml sample of milk from each quarter
for bacterial growth, 24 h and 48 h prior to infusion with
S. aureus. Despite the complete absence of any clinical
symptoms and a SCC < 50,000, one quarter of cow 1419
was found to have a low level S. aureus infection in the
milk sample that was collected 24 h but not 48 h prior to
the commencement of the experiment. As a consequence,
this quarter was excluded from the experiment. Immedi-
ately following morning milking the udders were washed
and disinfected. One quarter of the udder on each cow
was infused with 5 ml of pyrogen-free PBS (intra-animal
control), while the other three quarters of each cow
(except cow 1419) received a graded dose of S. aureus (5 ×
102 – 1 × 106 bacteria) (Table 1). Infusions were delivered
using a 4 cm infusion cannula inserted into the teat canal
and then massaged further along the teat canal and into
the udder tissue. The doses of bacteria were designed to
produce low level subclinical mastitis (i.e. SCC > 200,000
cells/ml) within 16 h after which a second sample of milk
(10 ml) was collected for diagnostic analysis before the
cows were euthanized. A 10–20 g sample of mammary tis-
sue was then surgically removed from each udder quarter
in less than 10 min, snap frozen in three segments in liq-
uid nitrogen and stored at -80°C. The secretory tissue
samples were taken from carefully selected regions of each
udder quarter avoiding large blood vessels and the cister-
nal region.
Diagnostic analyses of milk samples
Milk was collected according to a standard protocol [58]
before and after pathogen infusion and sent for analysis to
the Veterinary Pathology Diagnostic Services (University
of Sydney). Standard procedures were used for assessment
of bacterial content. The milk samples were assayed for
bacterial growth and colony characteristics, and cultured
bacteria were characterised using the Gram stain [59]. The
bacterial culture was identified and tested for haemolytic,
catalase and coagulase activities [60]. S. aureus was identi-
fied in cultures obtained from milk samples using the fol-
lowing criteria: growth and colony characteristics on
Sheep Blood agar from Oxoid (Oxoid Australia Pty Ltd.,
Victoria); Gram positive stain; haemolytic on blood agar
medium; catalase positive and coagulase positive. SCC
was determined using laser based flow cytometry of the
milk samples.
Preparation of RNA
Frozen mammary tissue (~3 g) was placed in liquid nitro-
gen, pulverised with a hammer, followed by addition of
25 ml of Trizol reagent (Invitrogen). The tissue was
homogenised using an Ultraturrax probe (IKA, 3 cycles of
2 s) and RNA extracted according to the manufacturer's
protocol (Invitrogen). RNA was further purified using an
RNeasy Midi Kit (Qiagen) and each sample was treated
twice with DNase I to eliminate contaminating genomic
DNA. The purified RNA was quantified by spectrophoto-
metric measurements and its purity and integrity verified
by the OD260/OD280 ratio ( > 1.8) and by visualisation on
a denaturing gel. Controls without reverse transcriptase
were also produced for qRT-PCR analyses to validate the
absence of genomic DNA.
Primer design and quantitative real time RT-PCR (qRT-
PCR)
All gene symbols are shown in italics when used in the
context of the gene or mRNA but when used in the context
of their encoded proteins they are denoted by normal text.
Quantitative Real-Time Reverse Transcription PCR (qRT-
Correlation between the Somatic Cell Count (SCC) and  S100A12 concentration in milk from dairy cattle Figure 8
Correlation between the Somatic Cell Count (SCC) 
and S100A12 concentration in milk from dairy cattle. 
The plot shows the correlation between S100A12 concen-
tration and SCC in milk from 38 dairy cows. The line of best 
fit drawn through the data has a correlation coefficient (R2) 
of 0.92. The SCC was determined by flow cytometry of milk 
samples and the S100A12 levels in milk whey were deter-
mined using the S100A12-specific antigen capture ELISA with 
rS100A12 as the standard.
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PCR) using the Sybr Green-based fluorescent detection
system and the ABI Prism 7900 Sequence Detection Sys-
tem (PE Applied Biosystems, Forster City, CA), was used
to measure mRNA abundance. Analysis of the data was
performed using the Relative Expression Software Tool
(REST), which generates a Mean Normalised Expression
(MNE) value of a target transcript relative to a reference
gene [61,62]. Primers were designed with the aid of
MacVector (ver 7.1) (Accelrys) software and publicly
available ovine and bovine sequences (Table 5). A con-
stant amount of cDNA (10 ng) was used for qRT-PCR
measurements. Four technical replicates were performed
for each gene investigated. In addition, three independent
cDNA samples were assessed for each tissue sample from
each cow. This process allowed quantification of the target
gene relative to a constant reference gene in each sample
using threshold cycle (Ct) data. Three potential reference
genes,  18S Ribosomal RNA (Genbank accession
DQ222453),  Glyceraldehyde 3-Phosphate Dehydrogenase
(Genbank accession XM_868165) and Ribosomal Protein,
large, P0 (RPLP0) (Genbank accession BT021080) were
independently measured in all samples at constant cDNA
input to determine which was the most suitable reference
gene. This analysis revealed that the expression pattern of
RPLP0 showed least variation and therefore it was used as
the reference gene.
Each qRT-PCR (5 μl) contained: 2.5 μl of 2× Sybr Green
Master Mix (Applied Biosystems); 0.25 μl of each primer
giving a final concentration of 450 nM each; 1.0 μl water;
and 1.0 μl of a 1/10 dilution of the stock cDNA template.
The reaction was started by heating (95°C, 10 min) to
activate the AmpliTaq Gold DNA polymerase. The cycling
conditions consisted of 40 cycles of 95°C for 15 s and
60°C for 1 min. All melt curves showed a single peak con-
sistent with the presence of a single specific amplicon.
Each qRT-PCR assay was validated by amplicon size and
sequence. Amplification efficiency was independently
measured for each amplicon [61]. Udder quarter differ-
ences in gene expression for each cow were analysed using
One-way ANOVA and P < 0.01 was considered statistically
significant.
cDNA microarray transcript profiling
The microarray experiments were performed using the
Bovine Innate Immune Microarray platform [28]. The
cDNA microarray comprises 1480 defined immune
related genes in duplicate and 5327 anonymous cDNAs
(in duplicate) from subtracted and normalised cDNA
libraries derived from bovine peripheral blood lym-
phocytes (PBL), bovine mammary epithelial cells (MAC-T
and bMEC) and bovine macrophages (BoMac), which
underwent a variety of immune challenges. In addition,
the microarray contains 384 control elements in quadru-
plicate and 49 orthologous ovine/bovine elements in
quadruplicate. In some cases a single gene is represented
by multiple elements. cDNA synthesis, labelling, microar-
ray hybridisation and washing, and data acquisition were
performed as previously described [28]. Data from each
cow were separately analysed relative to their intramam-
mary control as the initial qRT-PCR studies indicated that
there was considerable variation in the magnitudes of
individual cow responses for each tested gene. In the
microarray analysis, gene expression in each quarter
within a cow was directly compared to the gene expres-
sion in other quarters using an 'all pairs' design with recip-
rocal dye swaps i.e. in general, 12 microarrays were used
per cow and 6 measurements were made of each sample.
In this manner, each cow was initially independently ana-
lysed (Fig. 2). Data from these microarray experiments has
been submitted to the Gene Expression Omnibus [63]
(platform ID GPL6082, Series ID GSE9685).
Microarray statistical analysis
Statistical analysis of the microarray data was performed
as previously described [28]. The mixed model used for
the analysis of intensity expression signals accounted for
95.5% of the total variation. The main effect of probe and
the interactions between probe by array, probe by dye and
probe by dose accounted for 76.8%, 15.3%, 1.6% and
1.8%, respectively. These proportions are consistent with
previous studies applying mixed models to the analysis of
Antimicrobial activity of rS100A12 Figure 9
Antimicrobial activity of rS100A12. Antimicrobial activi-
ties of rS100A12 were measured using the Broth Microdilu-
tion Susceptibility Testing Method. (a) E. coli and (b) S. aureus. 
(n), rS100A12; (s) BSA at the same concentrations. Bars 
represent the means ± SEM for 2 replicates. The data were 
examined for significance using ANOVA and the asterisk 
denotes significant differences (P < 0.05) from the control.
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expression data and anticipate that, for an optimal control
of false discovery rate, approximately 1.8% of probes are
expected to be found differentially expressed in any given
contrast. The overall effects of S. aureus infection on mam-
mary gene expression were visualised using GeneSpring
5.1 (Silicon Genetics, Redwood City, CA). The mean sig-
nal intensity for each significantly differentially expressed
element, calculated using the statistical model described
above, was loaded into the software. Differentially
expressed elements, but limited to those with greater than
2 fold change in at least one sample and expression in all
samples, were identified by analysis of samples from indi-
vidual cows. The mean signal intensity for each treatment
dose was calculated and these values were normalised to
the mean signal intensity for the element in the intra-ani-
mal control sample. Thus, each differentially expressed
element had a normalised mean signal intensity value for
each  S. aureus dose i.e. 500 (n  = 1), 10,000 (n  = 2),
100,000 (n = 3) or 1,000,000 (n = 2) bacteria, compared
to the respective control samples. The reasons for the dif-
ferent number of biological samples with the different
doses related to a different infection regime for one cow
and the exclusion of one quarter in another cow from the
experiment. The resulting profiles were subsequently clus-
tered (K-means clustering) [30]. However, manual exam-
ination of these clusters in conjunction with the inherent
redundancy on the microarray revealed that they required
considerable consolidation. Consequently, the clusters
were manually condensed into two primary groups i.e. a
cluster of elements showing S. aureus-induced increased
expression and a cluster of elements showing S. aureus-
induced decreased expression.
Sequencing of cDNA clones
The Bovine Innate Immune Microarray comprised a sig-
nificant number of elements derived from anonymous
cDNA clones. The anonymous elements with expression
profiles that were significantly altered by S. aureus infec-
tion were sequenced using standard protocols (Applied
Biosystems, USA). The clipped EST sequences were sub-
mitted to the Genbank nucleotide sequence database with
accession numbers EW739703–EW741108[64]. Annota-
tions were added to the EST sequences by comparing
them to the Genbank non-redundant and Human RefSeq
nucleotide and amino acid databases using BLASTN and
BLASTX [65,66]. Gene names were assigned to ESTs if the
Expect score was less than 1 × 10-10. The predicted biolog-
ical functions of these genes were then determined
through extensive PubMed literature searches for ortholog
functions [64].
Challenge of bMEC with LPS and LTA
The culture and characterisation of the primary bovine
mammary epithelial cells (bMEC) have been described
elsewhere [12]. bMEC were grown in M199, Hams F12,
10 mM Hepes, 20 mM NaHCO3, 2 mM NaC2H3O2, 20%
horse serum, 5% FCS, 100 U/ml penicillin, 100 μg/ml
streptomycin, 250 ng/ml amphotericin B, 100 ng/ml kan-
amycin (all reagents from Invitrogen Corporation
Carlsbad, California), 5 μg/ml insulin, 1 μg/ml cortisol
(Sigma Chemical Co., St Louis), 10 ng/ml EGF (MP Bio-
medicals, Irvine, CA), pH 7.4. bMEC were seeded at 4 ×
104 cells per well in 6 well plates (Sarstedt) and grown
until 80% confluence at 37°C, then challenged with LPS
(50 μg/ml) or LTA (20 μg/ml) for 0, 2, 4, 8, 16 and 24 h.
The concentrations of LTA and LPS used with the bMEC
were determined from titration analyses [12]. LPS was
purchased as a lyophilised powder purified from E. coli
strain 055:B5 by phenol extraction (Sigma Chemical Co.)
[67]. LTA isolated from Streptococcus pyogenes was
obtained from Sigma Chemical Co [68].
Cloning, expression and purification of rS100A12 and 
rPTX3
The nucleotide sequence encoding bovine PTX3, without
the region encoding the signal sequence, was cloned into
Binding of rtnPTX3 to immobilised human C1q Figure 10
Binding of rtnPTX3 to immobilised human C1q. The 
binding of rtnPTX3 to immobilised human C1q was meas-
ured using an ELISA-based binding assay. The binding activi-
ties for two different preparations of rtnPTX3 (each 12.5 ng/
well) are shown. The controls consisted of PBS and BSA 
(12.5 ng/well). Significance was measured by ANOVA relative 
to the PBS control (*, P < 0.05).
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the bacterial expression vector pQE9 (Qiagen) and
expressed and purified according to the manufacturer's
instructions (primer sequences are listed in Table 5).
rPTX3 was identified by size, N-terminal sequence and its
reactivity with the Ni-NTA affinity resin and Ni-NTA HRP
conjugate. The protein was refolded [69] and dialysed into
50 mM Tris-HCl pH 8, 500 mM NaCl and 20 % glycerol.
The nucleotide sequence encoding bovine S100A12 was
cloned into the bacterial expression vector pQE9 (Qiagen)
(Table 5) and expressed as per the manufacturer's instruc-
tions. The recombinant protein (rS100A12) was expressed
in the cytoplasm and purified using Ni-NTA affinity chro-
matography (Qiagen). All buffers contained Complete
EDTA-free protease inhibitors (Roche Applied Science).
Protein quantities were determined using the BCA Protein
Assay kit (Pierce) with BSA as the standard. Endotoxin lev-
els in the recombinant proteins were less than 0.05 EU/ml
using the Cambrex Limulus Amebocyte Lysate (LAL) pyro
Plus Gel Cot assay (lonza, Basel, Switzerland)
N-terminal amino acid sequencing of rS100A12 and rPTX3
Purified rPTX3 and rS100A12 were blotted onto polyviny-
lidine fluoride (PVDF) membrane (Problot, Applied Bio-
systems) and their N-terminal amino acid sequences were
determined using a Procise Protein Sequencer (Applied
Biosystems). The sequences confirmed the expected N-ter-
minal sequences (underlined) i.e. MRGSHHHHHHGS
ENSDDY(rPTX3); MRGSHHHHHHGS
TKLEDHLE(rS100A12).
Production of polyclonal antibodies and development of 
S100A12 and PTX3-specific enzyme-linked 
immunosorbent assays (ELISAs)
Four aliquots, each of 50 μg of purified rPTX3 (in 6 M
urea), and four aliquots, each of 250 μg of purified
S100A12 (in PBS), were used for the production of rabbit
polyclonal antibodies (Institute of Medical and Veterinary
Science Polyclonal Antibody Production, Gilles Plains,
South Australia). Each rabbit was injected with one aliq-
uot of antigen (with adjuvant) 4 times at 3 week intervals.
Serum samples were collected from the rabbits 2 weeks
after the last injection. Antibodies to rPTX3 and rS100A12
were immunoaffinity purified [69]. Antigen-specific cap-
ture ELISAs were used to measure the concentrations of
endogenous S100A12 and PTX3 in milk whey samples.
The antigen capture ELISAs used the immuno-affinity
purified antibodies (500 ng/well and 100 ng/well for
S100A12 and PTX3, respectively) as capture antibodies
and biotinylated forms of the same antibodies (1 μg/ml)
for detection [69,70]. The biotinylated antibodies were
detected with HRP-streptavidin-biotin complex (Amer-
sham Life Science, UK) (1/500 in PBS). Milk samples were
centrifuged (2,500 × g, 20 min, 4°C), the cream layer
removed, recentrifuged (100,000 × g, 4°C, 30 min) and
filtered (0.45 μm filter). Milk whey was diluted 1 in 5 with
PBS for S100A12 and 1 in 2 for PTX3 detections and 100
μl added after coating the plate with the primary affinity
purified antibody. The concentrations of S100A12 and
PTX3 in milk whey were calculated from standard curves.
The S100A12-specific antigen capture ELISA was also used
to measure the concentrations of S100A12 in milk whey
samples obtained from 38 dairy cows (Corstorphine
Dairy, Camden NSW, Australia). The milk samples were
Direct binding of biotinylated E. coli to rtnPTX3 Figure 11
Direct binding of biotinylated E. coli to rtnPTX3. The 
binding of biotinylated E. coli (ATCC 35218) to rtnPTX3 
immobilised onto a nitro-cellulose membrane was measured. 
(a) PBS; (b) rPTX3 in duplicate (50 μg); and (c) BSA, in dupli-
cate (50 μg).
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stored in 30 ml herd recording tubes, each pre-loaded
with the milk preservative bromopol, and stored at 4°C.
The somatic cells in the milk samples were measured
using laser based flow cell cytometry with a Bentley Soma-
count 300 (Bentley Instruments Inc., Minnesota, USA)
[71]. Samples were warmed to 40°C prior to SCC analysis
to ensure all fat was mixed back in the sample.
SDS-PAGE and immunoblots
The conditions used for SDS-PAGE and immunoblotting
have been described elsewhere [72]. Unless specified, all
samples were run under reducing conditions. Immuno-
affinity purified antibodies to rS100A12 and rPTX3 were
used in the immunoblots at final concentrations of 1 and
0.5 μg/ml, respectively. The same concentration of puri-
fied rabbit antibodies from pre-vaccination serum did not
recognise either of the recombinant proteins in control
immunoblots.
Cloning, expression and purification of recombinant PTX3 
expressed in insect cells
The cDNA encoding the mature PTX3 polypeptide was
cloned into the insect cell expression vector pIEx5 (Nova-
gen) (Table 5). The vector encodes the signal peptide of
adipokinetic hormone thus potentially resulting in secre-
tion of the recombinant protein into the culture medium.
The plasmid was transformed into XL1-Blue cells and
purified using an Endo-free Maxi plasmid kit (Qiagen).
Trichoplusia ni insect cells (Protein Expression Facility,
University of Queensland) were grown in serum-free
Sf900-II® medium (GIBCO) (1.1 × 106 cells/ml) and tran-
siently transfected using 800 μl of Insect GeneJuice® trans-
fection reagent (Novagen) and 150 μg of endotoxin-free
plasmid for each 100 ml of cells [73]. Cells were grown at
28°C (120 rpm; 48 h) at and the culture medium contain-
ing secreted recombinant PTX3 (rtnPTX3) was harvested
(400 × g, 10 min). The medium was filtered, concentrated
and dialysed into 20 mM Tris-HCl, pH 8.0, 1 mM EDTA,
5 mM benzamidine. The rtnPTX3 was then purified using
anion exchange chromatography (Q-Sepharose).
Reduction and alkylation of rtnPTX3
Purified rtnPTX3 or rPTX3 (each 100 μg in 100 μl) were
mixed with an equal volume of 8 M urea in 20 mM Tris-
HCl, pH 8.0 to denature the protein. Dithiothreitol (15 μl
of 45 mM) was added and incubated at 50°C for 15 min.
Freshly prepared iodoacetamide (16.5 μl of 100 mM) was
subsequently added to the reduced samples which were
incubated in the dark at RT for 45 min.
Bacterial growth inhibition
Assays to measure inhibition of bacterial growth were per-
formed using the Broth Micro-dilution Susceptibility Test-
ing Method [45]. A frozen stationary culture of E. coli
(LE392) was streaked onto LB agar plates and a single col-
ony was subcultured in 6 ml of Muller-Hinton broth and
incubated at 37°C (200 rpm, 5 h). Mid-logarithmic
growth phase bacteria were diluted 1:250 in TBS, pH 7.2.
Two fold serial dilutions of rS100A12 and the controls
(antibiotics or BSA) were prepared in sterile polypropyl-
ene plates (Nunc, Roskilde, Denmark) compatible with
cationic peptides. Purified rS100A12 (50 μg/ml), control
antibiotics (25 μg/ml ampicillin and 12.5 μg/ml kanamy-
cin) and BSA (80 μg/ml) in TBS pH 7.2 were used in the
assays. Each plate also included wells containing the bac-
terial inoculum without any additives. Plates containing
10 μl of the diluted test compounds, 100 μl of 2× Muller-
Hinton broth and 80 μl of water were then inoculated
with 10 μl of diluted cultures (1 × 105 cfu/ml) in a final
volume of 200 μl of 1× strength Muller-Hinton broth and
Table 5: Oligonucleotide primer sequences used for qRT-PCR and recombinant protein expression
Gene Accession number Forward (5'→3') Reverse (5'→3') Size (bp) Ref.
RPLP0 BT021080 CAACCCTGAAGTGCTTGACAT AGGCAGATGGATCAGCCA 220 [12]
IL-1β M35589 AAATGAACCGAGAAGTGGTGTT TTCCATATTCCTCTTGGGGTAGA 185 [12]
IL-6 X57317 CTGGGTTCAATCAGGCGAT CAGCAGGTCAGTGTTTGTGG 206 [12]
IL-8 AF232704 CTGTGTGAAGCTGCAGTTCT TAAGCAGACCTCGTTTCCAT 180 [12]
TNFα NM_173966 CTGGTTCAGACACTCAGGTCCT GAGGTAAAGCCCGTCAGCA 183 [12]
CD14 D84509 GGTGCTACCCGATGTGTCTG AAGGGATTTCCGTCCAGAGT 191 [12]
CSN1S1 M38641 CCTGTCTTGTGGCTGTTGCTCTTG CATCTTCCTTTTGAATGTGCTTCTGCT 282 pc*
CSN2 M16645 TCTGCCTCTGCTCCAGTCTT AGGAGGGGGCATTCACTTT 251 pc*
S100A12 NM_174651 CATTTCGACACCCTCAACAA CTGTTTTCAGCACCCTGGAC 184
rS100A12 NM_174651 CCGGATCCACTAAGCTGGAAGATCAC
CTGGAGG
CCAAGCTTTACTCTTTGTGGATATCT
ATGTGGGCTG
-
PTX3 NM_001076259 TATGCCATGGTGCTTTCAGA CCAATGAACAATGGACAACAA 182
rPTX3 NM_001076259 ATGGATCCGAGAACTCAGATGATTATG
AGCTCATGTA
AGAAGCTTTTAATAAACATACTGTGC
TCCTCGTG
-
rtnPTX3 NM_001076259 GTGGATCCGGAGAACTCAGATGATTAT
GAGCTCATGTA
AGAAGCTTTTAATAAACATACTGTGC
TCCTCGTG
-
* Personal communication (Karen Matthews)BMC Veterinary Research 2008, 4:18 http://www.biomedcentral.com/1746-6148/4/18
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incubated for 24 h. The plates were examined after 16 h
and bacterial cell growth assessed by measuring the opti-
cal density at 620 nm (Spectramax Plus microplate reader,
Molecular Devices, Sunnyvale, CA, USA).
Binding of rtnPTX3 to bacteria
Colonies of low pathogenicity strains of S. aureus (ATCC
25923) [74] or E. coli (ATCC 35218) were grown in 50 ml
Falcon tubes containing 20 ml LB Broth (37°C, 16 h, 200
rpm). The bacterial cultures were pelleted (3,000 × g),
washed in PBS, pH 8.0 and diluted to an OD600 nm of 0.8
(2.5 × 109 bacteria/ml). 25 ml of each bacterial sample
was subsequently mixed with 25 mg of Sulfo-NHS-LC-
Biotin (Pierce) according to the manufacturer's recom-
mendations. Unbound biotin was removed by 3 washes
with PBS and the pellets resuspended in 25 ml of PBS, pH
8.0. rtnPTX3 (50 μg) was immobilised onto HyBond C
nitrocellulose (GE Healthcare Life Sciences) using a Bio-
Dot® SF Microfiltration Apparatus (BioRad). The negative
controls were PBS or BSA. The membranes were then
blocked using 5% BSA in TBS (0.05% Tween), washed
and incubated overnight with 2 × 109 biotinylated bacte-
ria (in 25 ml) with gentle rocking at 4°C. The membranes
were then washed and incubated with HRP-Streptavidin-
Biotin complex (1:500) in TBS for 2 h (RT), followed by
three washes with TBS. Colour was developed using
enhanced chemiluminescence (Pierce ECL Western Blot-
ting Substrate).
Binding of rtnPTX3 to human C1q
Binding of rtnPTX3 to human C1q was examined as pre-
viously described [43,46]. Briefly, 96-well plates were
coated with 500 ng of human C1q (Merck) in 100 μl of
PBS, pH 7.4 with 1 mM CaCl2 and 1 mM MgCl2 (4°C,
ON). Wells were washed with PBS plus 0.05% Tween 20,
blocked with 0.5% milk powder in PBS-Tween 20 (2 h at
RT) before addition of 100 μl of different preparations of
rtnPTX3 (each 12.5 ng) in PBS-Tween 20 (1 h at 37°C).
The wells were washed in PBS-Tween 20 and incubated
with 1 μg/ml of the immunoaffinity purified rabbit anti-
body raised to rPTX3 (1 h at 37°C), washed again and
incubated with 1 μg/ml of HRP-conjugated anti-rabbit
IgG (1 h at 37°C). After further washing, 200 μl of 2,2'-
azino-bis (3- ethylbenzthiazoline-6-sulfonic acid) was
added for 20 min. The reaction was stopped by addition
of 50 μl of 4% SDS and absorbance at 405 nm measured.
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